The Rounds Table

TBT – The Top Papers of 2022

12.16.2023 - By Dr. John Fralick and Dr. Michael FralickPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Welcome back Rounds Table Listeners! As we approach the end of 2023, let’s revisit five important research studies from 2022: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial (0:00 – 2:56) Tirzepatide Once Weekly for the Treatment of Obesity (2:56 – 6:00) Empagliflozin in Patients with Chronic Kidney Disease (6:00 – ...

The post TBT – The Top Papers of 2022 appeared first on Healthy Debate.

More episodes from The Rounds Table